Arkadi Mazin is a Science Journalist at The Times of Israel and Lifespan.io (Lifespan Extension Advocacy Foundation). He focuses on medicine and healthcare, exploring various medical specialties to provide insightful analysis and coverage on these critical topics. Arkadi's work has been featured in prominent publications, highlighting his expertise in the intersection of science and health.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Arkadi Mazin's coverage heavily focuses on scientific topics, particularly longevity, aging, health, and research. His articles predominantly cite data and are likely to value pitches supported by robust empirical evidence or expert analysis.
Given the prevalence of data citation in his work, Arkadi may be more receptive to pitches from experts who can provide statistical insights or share new research findings related to longevity and aging.
As there is no specific geographic focus mentioned for Arkadi's coverage, he may cover global scientific developments within the field of longevity and aging. When reaching out to him with a pitch, consider providing international perspectives or studies that have broader implications beyond a single region.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Arkadi Mazin
A new study has found that partial reprogramming mitigates the damage of myocardial infarction in mice by helping heart muscle cells to complete division [1]. When heart cells get stuck When a heart attack (myocardial infarction, MI) kills a patch of heart muscle, the adult mammalian heart cannot replace it, since the lost contractile muscle
By: Arkadi Mazin
A new study has suggested that T cells might retain a pro-inflammatory phenotype long after normal weight is regained following a period of obesity.
By: Arkadi Mazin
A new study has pit an advanced large language model against human physicians in tasks involving messy real-world patient records, and the LLM won.
By: Arkadi Mazin
In a new study, the popular supplement creatine seemed to add to some of the beneficial effects of power training for strength maintenance.
By: Arkadi Mazin
Dr. Junyue Cao's lab at The Rockefeller University develops ultra-high-throughput single-cell technologies and applies them to the biology of aging.
By: Arkadi Mazin
GLP-1 receptor agonists may not affect muscle mass any more than weight loss caused by caloric restriction, and this appears to be true for strength as well.
By: Arkadi Mazin
Scientists have found a way to drastically ramp up mouse immune responses to cancer along with flu and COVID-19 [1]. How to wake up the immune system Modern cancer immunotherapies only work for a minority of patients. The reason, broadly, is that many tumors are immunologically “cold”: they do not trigger, and/or actively suppress, the
By: Arkadi Mazin
Scientists have devised a CRISPR-based tool that can kill cells carrying a specific strand of RNA. The tested targets include cancerous and virus-infected cells [1]. Targeted assassination of cells CRISPR-based systems work by cutting or changing DNA at a particular spot, an ability that can be used to fix dangerous mutations, such as in the
By: Arkadi Mazin
Scientists have uncovered an unexpected function of the tau protein, which is mostly known for its role in Alzheimer's: helping encode long-term memory.
By: Arkadi Mazin
The longevity field remains small and starved for resources, especially the subfield devoted to the fundamental biology of aging, despite near-universal agreement that solving aging requires understanding it first. With VCs looking for clinical successes and state funding drying up for many projects, some enthusiasts are turning to a nonprofit model. That path is anything
